CPI-0610 - CAS 1380087-89-7
Catalog number: 1380087-89-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H16ClN3O2
Molecular Weight:
365.81
COA:
Inquire
Targets:
BET Bromodomain
Description:
CPI-0610, a benzazepine derivative, has been found to influence tumor cell growth at some extent by acting as a BET bromodomain inhibitor. IC50: < 500 nM for BRD4. It is still under a Phase I trial for Leukaemia, Lymphoma and sorts of other cancers.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Powder
Synonyms:
2-[6-(4-Chloro-phenyl)-1-methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetamide
Solubility:
10 mM in DMSO
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
CPI-0610 has been found to influence tumor cell growth at some extent by acting as a BET bromodomain inhibitor.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
InChIKey:
GCWIQUVXWZWCLE-UHFFFAOYSA-N
InChI:
InChI=1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9,16H,10H2,1H3,(H2,22,25)
Canonical SMILES:
CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl
Current Developer:
Constellation Pharmaceuticals; The Leukemia & Lymphoma Society
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related BET Bromodomain Products


CAS 1300031-52-0 GSK1324726A (I-BET726)

GSK1324726A (I-BET726)
(CAS: 1300031-52-0)

GSK1324726A (I-BET726) is a novel, potent, and selective small molecule inhibitor of BET proteins with high affinity to BRD2 (IC50= 41 nM), BRD3 (IC50= 31 nM), ...

PFI-3
(CAS: 1819363-80-8)

PFI-3, a potent and selective SMARCA2/4 bromodomain inhibitor, is a cell-permeable probe that binds avidly to the structurally-similar SMARCA4 bromodomain (Kd= ...

GSK2801
(CAS: 1619994-68-1)

GSK2801 is a A Selective Chemical Probe for BAZ2B/A bromodomains. BAZ2A/B belong to a family of ubiquitously expressed bromodomain containing proteins.probes/GS...

CAS 936091-14-4 TG101209

TG101209
(CAS: 936091-14-4)

TG101209 is a novel and potent JAK2 inhibitor. The induction of cytotoxicity was associated with inhibition of cell cycle progression and induction of apoptosi...

BET-IN-1
(CAS: 1422554-34-4)

BET-IN-1, an oxazole derivative, can be used as a bromodomain inhibitor

CAS 1619994-69-2 Bromosporine

Bromosporine
(CAS: 1619994-69-2)

Bromosporine, a broad spectrum inhibitor for bromodomains which play a key role in many cellular processes, is a chemical probe for bromodomain functional assay...

CAS 1446144-04-2 CPI-203

CPI-203
(CAS: 1446144-04-2)

CPI203 inhibits BRD4 in vitro and in cells, while does not affect BRD4 kinase activity in vitro.

CAS 1403764-72-6 PFI-1

PFI-1
(CAS: 1403764-72-6)

PFI-1 is a potent and highly selective protein interaction Inhibitor, which targets BET bromodomain. PFI-1 that efficiently blocks the interaction of BET BRDs...

CAS 202590-98-5 OTX015

OTX015
(CAS: 202590-98-5)

OTX015 a potent BET bromodomian inhibitor, which targets the BET bromodomain proteins 2, 3, and 4 (BRD). BRDs 2, 3, and 4 are considered potential cancer target...

Mivebresib
(CAS: 1445993-26-9)

Mivebresib is a BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce po...

CAS 2070014-93-4 PF-CBP1 HCl

PF-CBP1 HCl
(CAS: 2070014-93-4)

PF-CBP1, also known as PF-06670910, is an inhibitor of the CBP and p300 bromodomains (IC50s = 125 and 363 nM, respectively) with more than 100-fold selectivity ...

INCB-057643

INCB-057643 is a novel inhibitor of bromodomain and extra-terminal motif (BET) undergoing a phase I/II clinical trial for the advanced malignancy therapy. The s...

Olinone
(CAS: 1770789-37-1)

Olinone, a pyridoindol derivative, has been found to be an BET Bromodomain inhibitor and could be probably useful in sorts of biological studies.

BET bromodomain inhibitor
(CAS: 1505453-59-7)

An BET bromodomain inhibitor can be used for the treatment of hematologic malignancies. It binds BET proteins to suppress the interaction between these proteins...

CAS 1044870-39-4 RVX-208

RVX-208
(CAS: 1044870-39-4)

RVX-208 is a potent inhibitor of BET bromodomains. RVX-208 functions by removing atherosclerotic plaque via reverse cholesterol transport (RCT). RVX-208 increas...

GSK6853
(CAS: 1910124-24-1)

GSK6853 is a potent (pKd 9.5), soluble, cell active (20 nM), and highly selective inhibitor of the BRPF1 bromodomain with greater than 1600-fold selectivity ov...

CPI-0610
(CAS: 1380087-89-7)

CPI-0610, a benzazepine derivative, has been found to influence tumor cell growth at some extent by acting as a BET bromodomain inhibitor. IC50: < 500 nM for BR...

CAS 1923851-49-3 GSK9311

GSK9311
(CAS: 1923851-49-3)

GSK9311 is a potent and selective inhibitor of the BRPF bromodomain (pIC50= 6.0 and 4.3 for BRPF1 and BRPF2, respectively).

PFI-4
(CAS: 900305-37-5)

PFI-4 is a potent and selective BRPF1 bromodomain inhibitor with IC50 of 80 nM.

CAS 936091-26-8 TG101348

TG101348
(CAS: 936091-26-8)

Quick Inquiry

Verification code

Featured Items